Recruiting
Efficacy, Safety, and Tolerability of NBI-1065890 Versus Placebo in Adults With Tardive Dyskinesia
NCT07365462
- Conditions
- Central Nervous System Diseases, Dyskinesia, Drug-Induced, Dyskinesias, +6 more
- Locations
-
- Neurocrine Clinical Site Bryant, Arkansas, United States
- Neurocrine Clinical Site Chino, California, United States
- Neurocrine Clinical Site Fountain Valley, California, United States
- Neurocrine Clinical Site Huntington Beach, California, United States